ControversiesChallengesConsensus

Ulf Teichgräber discusses the EffPAC trial 12-month results which were presented for the first time at CX 2018

Ulf Teichgräber discusses the EffPAC trial 12-month results which were presented for the first time at CX 2018
Ulf Teichgräber, Jena, Germany

2018-04-26T13:54:50+00:00